235 related articles for article (PubMed ID: 19506396)
1. Acute pancreatitis in a girl with panhypopituitarism due to craniopharyngioma on growth hormone treatment. A combination of risk factors.
Faienza MF; Delvecchio M; Indrio F; Francavilla R; Acquafredda A; Cavallo L
Horm Res; 2009; 71(6):372-5. PubMed ID: 19506396
[TBL] [Abstract][Full Text] [Related]
2. Patients with craniopharyngiomas: therapeutical difficulties with growth hormone.
Cannavò S; Marini F; Trimarchi F
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):56-60. PubMed ID: 19020388
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone treatment in pituitary insufficiency: selected cases of children with craniopharyngioma and medulloblastoma.
Kedzia A; Obara-Moszyńska M; Korman E; Rabska-Pietrzak B; Kopinski P; Trojan J; Goździcka-Józefiak A
Rocz Akad Med Bialymst; 2003; 48():28-33. PubMed ID: 14737937
[TBL] [Abstract][Full Text] [Related]
4. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
[TBL] [Abstract][Full Text] [Related]
5. Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy.
Inge TH; Pfluger P; Zeller M; Rose SR; Burget L; Sundararajan S; Daniels SR; Tschöp MH
Nat Clin Pract Endocrinol Metab; 2007 Aug; 3(8):606-9. PubMed ID: 17643131
[TBL] [Abstract][Full Text] [Related]
6. Hypopituitarism oddities: craniopharyngiomas.
Karavitaki N
Horm Res; 2007; 68 Suppl 5():151-3. PubMed ID: 18174734
[TBL] [Abstract][Full Text] [Related]
7. Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence.
Losa M; Castellino L; Pagnano A; Rossini A; Mortini P; Lanzi R
J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32112101
[TBL] [Abstract][Full Text] [Related]
8. [Children with craniopharyngioma, a 'benign' brain tumor with a high morbidity].
Taphoorn MJ; van Es C; Gooskens RH; de Vroede M; Jennekens-Schinkel A; Vandertop WP
Ned Tijdschr Geneeskd; 2000 Sep; 144(36):1705-9. PubMed ID: 10992890
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of growth hormone replacement therapy in adults.
Toogood A
Expert Opin Drug Saf; 2005 Nov; 4(6):1069-82. PubMed ID: 16255665
[TBL] [Abstract][Full Text] [Related]
10. HORMONE SUBSTITUTION AFTER GASTRIC BYPASS SURGERY IN PATIENTS WITH HYPOPITUITARISM SECONDARY TO CRANIOPHARYNGIOMA.
Wolf P; Winhofer Y; Smajis S; Kruschitz R; Schindler K; Gessl A; Riedl M; Vila G; Raber W; Langer F; Prager G; Ludvik B; Luger A; Krebs M
Endocr Pract; 2016 May; 22(5):595-601. PubMed ID: 26789341
[TBL] [Abstract][Full Text] [Related]
11. Replacement therapy with growth hormone and pituitary tumor recurrence: the relevance of the problem.
Losa M; Gatti E; Rossini A; Lanzi R
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):75-8. PubMed ID: 19020392
[TBL] [Abstract][Full Text] [Related]
12. Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children.
Jeschke MG; Finnerty CC; Kulp GA; Przkora R; Mlcak RP; Herndon DN
Pediatr Crit Care Med; 2008 Mar; 9(2):209-16. PubMed ID: 18477935
[TBL] [Abstract][Full Text] [Related]
13. Management of growth hormone deficiency in adults.
Nilsson AG; Svensson J; Johannsson G
Growth Horm IGF Res; 2007 Dec; 17(6):441-62. PubMed ID: 17629530
[TBL] [Abstract][Full Text] [Related]
14. [Excessive growth and growth hormone deficiency after treatment for craniopharyngioma].
López Siguero JP; García García E; Martínez-Aedo MJ; Martínez Valverde A
An Esp Pediatr; 2000 Jul; 53(1):64-6. PubMed ID: 10998409
[TBL] [Abstract][Full Text] [Related]
15. [Pathological daytime sleepiness in an 11-year old girl receiving growth hormone treatment previously cured from craniopharyngioma].
Korpal-Szczyrska M; Birkholz D; Okońska M; Pawłowicz M; Szczyrski J
Pediatr Endocrinol Diabetes Metab; 2012; 18(4):158-62. PubMed ID: 23739621
[TBL] [Abstract][Full Text] [Related]
16. Physiological growth hormone replacement and rate of recurrence of craniopharyngioma: the Genentech National Cooperative Growth Study.
Smith TR; Cote DJ; Jane JA; Laws ER
J Neurosurg Pediatr; 2016 Oct; 18(4):408-412. PubMed ID: 27286443
[TBL] [Abstract][Full Text] [Related]
17. Long-term Effects of Growth Hormone Replacement Therapy in Childhood-onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (HIT-Endo).
Boekhoff S; Bogusz A; Sterkenburg AS; Eveslage M; Müller HL
Eur J Endocrinol; 2018 Oct; 179(5):331-341. PubMed ID: 30139824
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and management of deep venous thrombosis in children following post-surgical hypopituitarism in craniopharyngioma.
Chandrakasan S; Sood S; Ham S; Moltz K; Frey MJ; Rajpurkar M
Pediatr Blood Cancer; 2011 Jul; 57(1):175-7. PubMed ID: 21557464
[No Abstract] [Full Text] [Related]
19. [Effect of recombinant human growth hormone therapy on metabolic parameters in patients with craniopharyngioma].
Mao JF; Wang X; Xiong SY; Zheng JJ; Yu BQ; Nie M; Wu XY; Qi ST
Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(42):3286-3290. PubMed ID: 29141371
[No Abstract] [Full Text] [Related]
20. Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database).
Darendeliler F; Karagiannis G; Wilton P; Ranke MB; Albertsson-Wikland K; Anthony Price D; On Behalf Of The Kigs International Board
Acta Paediatr; 2006 Oct; 95(10):1284-90. PubMed ID: 16982503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
